In this study, 36.6 per cent of the goats were found to be positive by the immunochromatographic test. The definitive diagnosis of enterotoxaemia is mostly based only on the detection of epsilon toxin in the intestinal contents and other supportive tests could be measurement of urine glucose levels or examination of Gram-stained smears of intestinal mucosa
(Smith and Sherman, 2011). Molecular test like, multiplex PCR is generally used for toxin genotyping of
C.
perfringens (Mohiuddin et al., 2016). Recently, immuno chromatographic test is found to detect ETX with fivefold detection limits in different matrices such as serum and intestinal contents
(Feraudet-Tarisse et al., 2017). The peripheral blood smears revealed no blood parasites from all the cases.
The clinical signs observed are in consistent with that of
Smith and Sherman (2011) and
Ortega et al., (2019). Diarrhoea was the most consistent finding which is due to enterocolitis in acute cases and initial softening of faeces in sub acute cases
(Pawaiya et al., 2020). The nervous signs observed could be associated with ETX that was known to stimulate the release of glutamate, an excitatory neurotransmitter, by targeting the hippocampal glutamatergic system
(Lonchamp et al., 2010 and
Popoff, 2011) or vasogenic edema and neuronal toxicity
(Morris et al., 2017). Brain is a prime target of epsilon toxin which initially binds to endothelial cells of the blood-brain-barrier (BBB), resulting in swelling, vacuolation and necrosis and thereby leakage of fluid and proteins, hypoxia of the neural parenchyma
(Stiles et al., 2013). However,
Kumar (2019) and
Singh (2017) observed brain changes as inconsistent in caprine enterotoxaemia. The damage to the vascular endothelium leads to the accumulation of protein-rich fluid effusions in heart, brain and lung
(Constable et al., 2017).
In this report, neutrophilia and leukocytosis were observed in majority of the cases (90.0%) of enterotoxaemia and statistically, a highly significant increase (P<0.001) in the neutrophilsand leukocytes count and a highly significant decrease (P<0.001) in the lymphocyte count were noticed in the positive cases when compared to the controls. Reduction in total erythrocyte count (TEC) was observed in 40.0 per cent of the cases, however, statistically, no significant difference was observed in positive cases when compared to controls. The findings are in accordance with
Kumar (2019) who observed a significant increase in the white blood cells (WBC) in affected goats, with a significant reduction in mean erythrocyte (RBC) count and haemoglobin level. Reduction in RBC levels could be associated with haemorhhagic enteritis caused by the ETX and the leukocytosis with clostridial proliferation in the GI tract.
In this report, elevated blood urea nitrogen (BUN) creatinine, glucose, sodium, alkaline phosphatise (ALP) and chloride levels were observed in positive cases. Statistically, a significant increase (P<0.05) in the levels of BUN, creatinine, glucose, ALP and chloride levels was observed, and statistically a significant increase (P<0.001) in the sodium level was observed. This finding was in accordance with
Khan et al., (2017) who recorded a significant increase in blood glucose, liver enzymes, serum creatinine, total bilirubin caprine enterotoxaemia, pulpy kidney was not consistently reported, but with petechial and ecchymotic subcapsular haemorrhages
(Uzal et al., 1994).Pronounced hyperglycem, blood urea and glucose in goats affected with enterotoxaemia.
The elevated BUN and creatinine could be associated with lesions in kidney. However, in ia (150 to 200 mg/dL) due to the mobilization of hepatic glycogen and marked glycosuria are reported to be characteristic in the terminal stage of enterotoxaemia
(Constable et al., 2017). Glycosuria is said to be strongly indicative of enterotoxaemia in both sheep and goats
(Uzal and Songer, 2008), where as
Pawaiya et al., (2020) reported the hyperglycaemia and glycosuria to be inconsistent in goats.
All the animals were treated with parentral administration of sulphadimidine @ 150 mg /kg body weight to prevent further growth of the bacterium and toxin production, flunixin meglumin @2.2 mg//kg body weight to alleviate toxaemia, mannitol @2.0 gms/kg body weight to reduce the cerebral oedema, diazepam @ 0.5/kg body weight as an anticonvulscent, dextrose normal saline and Ringer’s lactate to alleviate dehydration along with recommendation of oral sulphadimidine, activated charcoal as toxin binder, bloat relieving suspension and rumenotorics
(Smith and Sherman, 2011). However, all the cases were not presented for follow up therapy which might possibly be due to the fatal outcome of the disease, as the treatment is generally not effective due to acute nature of the disease.